Is Atrys Health, S.A. (ATRY.MC) a Buy, Sell, or Hold?
BME : ATRY.MC
Atrys Health, S.A.
$2.48 EUR
$0.03 (1.22%)
- Volume
- 59.82K
- Average Volume
- 65.25K
- Market Capitalization
- $188.28M
- P/E Ratio
- -1.88
- Dividend Yield
- 0.00%
- Price Target
- Year High
- $3.59
- Year Low
- $2.31
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $0.81
Company Overview
BME
Marian Isach
Biotechnology
Healthcare
ATRY.MC
553
ES
EUR
Liquidity Metrics
1.70
0.81
0.80
0.04
0.00
Sales & Valuation
$141.01M
1.34
1.24
-13.38
-0.18
Profitability
-$1.32
-$100.3M
-71.13%
-39.86%
-51.00%
-20.30%
P/E Metrics
-1.88
0.01
0.01
Analyst Price Target & Rating
1/5
0 Analysts
%
Financial Health Scores
0.40
5/9
-$56.46M
$494.04M
$342.08M
-$35.26M
Key Metrics (TTM)
No key metrics data available.
Company Executives
| Name | Title |
|---|---|
| Luis Duran | Global Chief Technology Officer |
| Roberto Lapieza | Sales Director |
| Alberto Castaneda Gonzalez | Secretary |
| Marian Isach | Chief Executive Officer & Executive Director |
| María Rosa González Sans | Managing Director of Prevention |
| Santiago De Torres Sanahuja | Executive Chairman |
| Alberto Iriondo | Chief Financial Officer |
| Isabel Lozano Fernandez | Executive Director |
| Jose Maria Huch Ginesta | Chief Financial Officer |
| Carlos Cordon-Cardo | Founder & Scientific Vice President |
| Zvi Fuchs | Founder and Medical Vice President |
| Inigo Valcaneras | Director of Operations |
| Pedro Salord | People Director |
Poll Results
No votes yet today — be the first to share your view!
About Atrys Health, S.A. (BME:ATRY.MC) Stock
Atrys Health, S.A., a biomedical enterprise founded in 2007 and based in Madrid, Spain, specializes in providing a range of diagnostic services and medical treatments. Its diagnostic portfolio encompasses areas like pathology, hematology, molecular pathology, and genetics, supplemented by offerings such as diagnostic second opinions, a comprehensive test directory, and support for clinical trials and research & development. The company effectively utilizes telemedicine to deliver its expertise in medical specialties including radiology, cardiology, ophthalmology, and dermatology. Furthermore, Atrys Health administers radiotherapy and is engaged in the development of innovative therapeutic approaches and diagnostic instruments. The organization operated as Althia Health, S.L. before rebrand ... ing to Atrys Health, S.A. in May 2016.
Frequently Asked Questions
-
What is the current Atrys Health, S.A. (ATRY.MC) stock price?
-
Atrys Health, S.A.(BME:ATRY.MC) stock price is $2.48 in the last trading session. During the trading session, ATRY.MC stock reached the peak price of $3.59 while $2.31 was the lowest point it dropped to. The percentage change in ATRY.MC stock occurred in the recent session was 1.22% while the dollar amount for the price change in ATRY.MC stock was $0.03.
-
ATRY.MC's industry and sector of operation?
-
The BME listed ATRY.MC is part of Biotechnology industry that operates in the broader Healthcare sector.
-
Who are the executives of ATRY.MC?
-
Luis Duran | Global Chief Technology Officer
Roberto Lapieza | Sales Director
Alberto Castaneda Gonzalez | Secretary
Marian Isach | Chief Executive Officer & Executive Director
María Rosa González Sans | Managing Director of Prevention -
How many employees does ATRY.MC have?
-
Number of ATRY.MC employees currently stands at 553. ATRY.MC operates from Calle VelAzquez, 24, Madrid, CT 28001, ES.
-
Link for ATRY.MC official website?
-
Official Website of ATRY.MC is: https://www.atryshealth.com
-
How do I contact ATRY.MC?
-
ATRY.MC could be contacted at phone #34 91 781 94 65 and can also be accessed through its website. ATRY.MC operates from Calle VelAzquez, 24, Madrid, CT 28001, ES.
-
How many shares of ATRY.MC are traded daily?
-
The average number of ATRY.MC shares traded daily for last 3 months was 65.25K.
-
What is the market cap of ATRY.MC currently?
-
The market value of ATRY.MC currently stands at $188.28M with its latest stock price at $2.48